Global Epigenetics Market to Reach USD 3.0 Billion by 2028 – Powered by Increased Investment in the Healthcare AR and VR – Vantage Market Research – QNT Press Release


WASHINGTON, Feb. 21, 2022 (GLOBE NEWSWIRE) — Vantage Market Research’s recent analysis of the Global Epigenetics Market finds that increasing cancer rates may further expediting market growth. Primarily driven by increasing research activity and funding for Epigenetics, the total Global Epigenetics Market is estimated to reach USD 3.0 Billion by 2028.

The market stood at a revenue of USD 0.8 Billion in the year 2021, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 13.1%.

Furthermore, the increasing personalized medication, and target therapy are also anticipated to augment the growth of the Global Epigenetics Market, states Vantage Market Research, in a report, titled “Epigenetics Market by Product (Instruments, Reagents & Kits, Others), by Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases), by Technology (Methylation, Acetylation, Phosphorylation, Other Technologies), by Region (North America, Europe, Asia Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)”.

Click Here To Access The Free Sample Report @

(The Free Sample Of This Report Is Readily Available On Request.)

Our Free Sample Reports Includes:

  • In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
  • Impact Analysis 130+ Pages Research Report (Including latest research).
  • Provide chapter-wise guidance on request 2021 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
  • Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Vantage Market Research methodology.

(Please note that the sample of this report has been updated to include the COVID-19 impact study prior to delivery.)

List of Prominent Players in the Epigenetics Market:

  • Illumina (US)
  • Thermo Fisher Scientific (US)
  • Merck Millipore (US)
  • Abcam (UK)
  • Active Motif (US)
  • Bio-Rad Laboratories (US)
  • New England Biolabs (US)
  • Agilent (US)
  • QIAGEN (Netherlands)
  • Zymo Research (US)
  • PerkinElmer (US)
  • Diagenode (Belgium)

Market Dynamics:

Driver: Increasing Cases of Cancer to Fuel Global Epigenetics Market

A significant increase in the number of individuals suffering from cancer. WHO counts, the number of people suffering from cancer is predicted to rise to 19.3 million by 2025 from 14.1 million in 2012. Cancer is the second-highest reason for death in western countries and accounts for nearly 1 in every 4 deaths. Epigenetic modifications like the dysregulation of DNA methylation are connected to cancer development and improvement. It offers new possibilities for emanating therapeutic techniques developed to change dysregulation in cancer.

Restraint: High Cost of Apparatus to Hamper the Market Growth

Instruments required for Epigenetics analysis are pricey as they are fitted with advanced features and functionalities. Pharmaceutical companies and investigation laboratories require many such systems. Therefore, significant investments are required for procuring considerable, high-cost genomic tools. End-users such as academic analysis laboratories find it challenging to afford such practices as they have tightened budgets. High apparatus costs, therefore, hinder their wide acceptance, which is anticipated to restrict the market growth during the projected period.

Purchase This Premium Report Now @

Benefits of Purchasing Epigenetics Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while Estimating the current and forecast market size and growth trends of the market …

Full story available on


Source link

Recommended For You

About the Author: News Center